For: | Samson M, Bonnotte B. Comment appliquer les recommandations EULAR et ACR pour le diagnostic et le traitement de l’artérite à cellules géantes ? La Revue de Médecine Interne 2022. [DOI: 10.1016/j.revmed.2022.02.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis] |
---|
Number | Citing Articles |
1 | Dumain C, Broner J, Arnaud E, Dewavrin E, Holubar J, Fantone M, Wazières B, Parreau S, Fesler P, Guilpain P, Roubille C, Goulabchand R. Patients' Baseline Characteristics, but Not Tocilizumab Exposure, Affect Severe Outcomes Onset in Giant Cell Arteritis: A Real-World Study. J Clin Med 2022;11. [PMID: 35683507 DOI: 10.3390/jcm11113115] [Reference Citation Analysis] |